Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000950135-08-000998
Filing Date
2008-02-14
Accepted
2008-02-14 14:41:11
Documents
1
Group Members
PETER KOLCHINSKYRA CAPITAL BIOTECH FUND II, L.P.RA CAPITAL BIOTECH FUND, L.P.RICHARD H. ALDRICH

Document Format Files

Seq Description Document Type Size
1 VASOGEN, INC. (RA CAPITAL MANAGEMENT, LLC) SC 13G/A b68591visc13gza.htm SC 13G/A 86282
  Complete submission text file 0000950135-08-000998.txt   88298
Mailing Address 2505 MEADOWVALE BOULEVARD MISSISSAUGA A6 L5N 5S2
Business Address 2505 MEADOWVALE BOULEVARD MISSISSAUGA A6 L5N 5S2 (905) 817-2000
VASOGEN INC (Subject) CIK: 0001042018 (see all company filings)

EIN.: 999999999 | Fiscal Year End: 1130
Type: SC 13G/A | Act: 34 | File No.: 005-79113 | Film No.: 08613666
SIC: 3841 Surgical & Medical Instruments & Apparatus

Mailing Address 111 HUNTINGTON AVE, SUITE 610 BOSTON MA 02199
Business Address 111 HUNTINGTON AVE, SUITE 610 BOSTON MA 02199 617-778-2512
RA CAPITAL MANAGEMENT, LLC (Filed by) CIK: 0001346824 (see all company filings)

EIN.: 830406777 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A